Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer - Wikidata - wikimedia - TriplyDB

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer

http://www.wikidata.org/entity/Q34252397

about

Targeting the adaptive molecular landscape of castration-resistant prostate cancer Integrative clinical genomics of advanced prostate cancer.The Molecular Taxonomy of Primary Prostate Cancer.Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.Frequent mismatch-repair defects link prostate cancer to Lynch syndrome Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.Biallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate Tumors Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.Translational and clinical implications of the genetic landscape of prostate cancer.Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.A mononucleotide repeat in PRRT2 is an important, frequent target of mismatch repair deficiency in cancer.Intratumoral heterogeneity of intrahepatic cholangiocarcinoma.Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate Immunotherapy of Prostate Cancer: Facts and Hopes.Prospects for the use of ipilimumab in treating advanced prostate cancer.Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.Targeting persistent androgen receptor signaling in castration-resistant prostate cancer.The molecular underpinnings of prostate cancer: impacts on management and pathology practice.Treatment strategies for DNA repair-deficient prostate cancer.A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.Applying Ancestry and Sex Computation as a Quality Control Tool in Targeted Next-Generation Sequencing.Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.Mapping the STK4/Hippo signaling network in prostate cancer cell.LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.Longitudinal analysis of treatment-induced genomic alterations in gliomas.Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer.Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.MSH2 Loss in Primary Prostate Cancer.The molecular biology of prostate cancer: current understanding and clinical implications.Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.Genetic mechanisms of immune evasion in colorectal cancer.Mismatch repair enzyme expression in primary and castrate resistant prostate cancer.Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification.Prostate cancer in the era of "Omic" medicine: recognizing the importance of DNA damage repair pathways.Microsatellite instability in prostate cancer by PCR or next-generation sequencing.

P2860

Q27022821-44EDC56F-091B-4AB3-8039-3D92E6C11A37 Q27853170-F4FF7ED2-04A4-444B-AADF-702E1DCDF9A3 Q34674332-B7EEF75A-2C83-42C6-B009-5744C1299336 Q35407284-2D58D44C-2D98-4944-803A-E0B7627DEA9C Q35969934-E2327343-A3C7-4006-BC49-8B87C10DE554 Q36345181-2308B493-FD6D-4E4D-A5CD-3CC8EDD37838 Q36545434-CF192C89-CC00-4B41-9380-BF2C205C4363 Q36646352-9F8FFA89-BFF9-40C8-BE1F-4F774214C526 Q36891144-660395AB-DDF6-48C7-B53C-779999D65F87 Q37179254-E3A13CEB-0221-4FE7-B128-ECCAAA3D5B0F Q37270512-1C3949C6-2318-4949-B4D4-0CB8A4D609C5 Q37302524-1342225D-5AE0-4C87-BCE9-B4C27065F620 Q37701535-C40AB482-6F19-489B-9396-40376AA396F3 Q37716471-0EFA2A73-4430-43D2-B59A-21EC025116FA Q38377884-DA6B68DF-5B82-46C8-91DE-89ED33478584 Q38664882-0519E659-C0CB-4E0A-956F-6EB87ED2EB80 Q38677420-240BB925-C55E-4822-B9A9-1B44C1D37D9D Q38768101-1B4BD5E2-1ABA-4AE0-8EB2-AB51B46C1BFA Q38771232-F01C2B69-E8D1-47D9-B62D-B45CCC01F536 Q38774228-A73E6105-CEC2-4BA6-8DA9-B3330708C9FF Q38797560-42D8FB93-1412-4529-AE59-A9E43D1A42D1 Q38983790-83575184-3524-4C9C-BC49-318E0A4D3390 Q39345771-39D241C5-924A-446B-912D-888B0806102A Q39775985-A1DE911E-49B5-48DA-9F8A-631ED0B336BF Q39813483-5D58AEC0-A370-46EE-845C-9273154AF862 Q39870818-A8E7D476-674B-47DE-8F9C-9894A1BC4F0A Q41569513-53303CFC-8A96-456D-8983-53F38E2763D5 Q42315779-3A1921E5-2BCB-4717-B415-8128A2487F2A Q42324248-E4C02EC7-7071-42E1-9868-88B009E2FCE7 Q42324670-06F8D0D6-92E1-438E-A637-AFB8EFBC8FA8 Q47725386-54D7B93F-5222-4512-A323-E69A724A889A Q47976701-965C5559-A95B-4AB6-90EB-05A049F432F6 Q49546811-6830CB11-6988-4A01-B7C5-33699A3F9C91 Q50030814-CA3A92BF-439D-4C0F-A3FD-56574243921E Q50420634-66CD6915-3EB1-417B-871C-A2685E7B9FE6 Q51789451-5AF6BD18-39D4-46D1-9354-3B04E75CC622 Q52566012-94F76274-5257-4773-B6AA-1F8400DC2A55 Q52629153-C87512CA-BED4-4DA8-BAB6-0050D8893E9F Q55172706-6B96EA63-D5F9-4A05-BACA-7A3BA31B13F1 Q55264193-D5175C9D-2DE5-4CAD-9301-A3E8B0C61004

P2860

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer

http://www.wikidata.org/entity/Q34252397

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Complex MSH2 and MSH6 mutation ...... table advanced prostate cancer

@ast

Complex MSH2 and MSH6 mutation ...... table advanced prostate cancer

@en

Complex MSH2 and MSH6 mutation ...... table advanced prostate cancer

@nl

type

label

Complex MSH2 and MSH6 mutation ...... table advanced prostate cancer

@ast

Complex MSH2 and MSH6 mutation ...... table advanced prostate cancer

@en

Complex MSH2 and MSH6 mutation ...... table advanced prostate cancer

@nl

prefLabel

Complex MSH2 and MSH6 mutation ...... table advanced prostate cancer

@ast

Complex MSH2 and MSH6 mutation ...... table advanced prostate cancer

@en

Complex MSH2 and MSH6 mutation ...... table advanced prostate cancer

@nl

P1433

Q34252397-43B70A01-FD4F-40CE-ACB8-73E7EB2A8700

P1476

Q34252397-B1698861-3F11-49CB-98C4-825A9DB3E0A4

P2093

Q34252397-2887422D-D550-4064-B4C1-256F24EF651B

Q34252397-2CB63665-3133-4E87-9839-85B2C3560D52

Q34252397-40D17D7B-9116-498A-AE94-97C0B92FB50B

Q34252397-4B799455-922C-4137-AFBF-ABF440C52138

Q34252397-56C8B7FE-6DB8-4739-9CD1-2C76D774709A

Q34252397-58AA285B-4043-468D-83BB-53901F3C5EF3

Q34252397-8433FA79-8FAF-4E8B-A890-D16754AA313B

Q34252397-94C4516D-8293-4D31-A53F-BC381D492A11

Q34252397-B788CA49-376D-4CE1-9ED4-67F55BDE8067

Q34252397-C0720BC1-1CD9-4118-8FCC-29D386C7810F

P2860

Q34252397-18A7FF56-09EE-49D6-BC7D-CB7810990DE1

Q34252397-1AAF9A5F-E7A0-4F2D-8CC1-2AA17A542994

Q34252397-24779CC8-2001-447F-A855-75E708149D21

Q34252397-248C6608-BBF4-4BA0-9EF4-34E76529C34A

Q34252397-303EE0AF-A9D2-4E1D-8FDC-ED330C0C5DEB

Q34252397-44F177C6-B90F-43D9-A452-76C396FA42DC

Q34252397-4FB962BC-7542-42B0-81FA-84663DD9275C

Q34252397-522499A6-FF5F-4C72-84D9-C8860DD45394

Q34252397-5AADC074-6630-4CF9-8F70-D1107184F1C7

Q34252397-6477180C-A468-486B-9AB5-9E02462162DB

P2888

Q34252397-A491F1A9-EDED-4FB1-940C-63BD2A492384

P304

Q34252397-CAF54542-DD3D-4FC3-90BD-EFE5F7AFF3B0

P31

Q34252397-80F264E4-F7A8-415A-BF18-264E9F608C04

P356

Q34252397-65BD2CCC-E947-44F1-97FE-9734A37058B9

P407

Q34252397-1C262CE8-3458-49AB-BFFA-81EC7AA96CFF

P478

Q34252397-E243C1B0-6067-40F4-BB04-0EB1917DD0B4

P50

Q34252397-3608C411-2D0A-43AF-AE5A-88EC5BE5853B

Q34252397-8CDA8C48-6F49-4924-97FA-B85AB249AF34

P577

Q34252397-15213D44-8FF6-4531-BC84-5288E121951C

P5875

Q34252397-CD6AEE40-5C86-44D5-A712-1EAC1B2AD74E

P6179

Q34252397-CA2AD213-9A8C-475B-B076-E51C73BBE7D4

P698

Q34252397-000B2084-23C9-4269-8CAE-EAA9001D1A6C

P921

Q34252397-DABD6A03-D75E-4A88-953C-DFA26E4BAC1B

P932

Q34252397-8C1F7AEA-0C7E-4A71-9E06-F2E006F0E9BC

P356

P1433

Nature Communications

P1476

Complex MSH2 and MSH6 mutation ...... table advanced prostate cancer

@en

P2093

Akash Kumar

http://www.w3.org/2001/XMLSchema#string

Christina Smith

http://www.w3.org/2001/XMLSchema#string

Colin C Pritchard

http://www.w3.org/2001/XMLSchema#string

Colm Morrissey

http://www.w3.org/2001/XMLSchema#string

Eva Corey

http://www.w3.org/2001/XMLSchema#string

Ilsa Coleman

http://www.w3.org/2001/XMLSchema#string

Jennifer Milbank

http://www.w3.org/2001/XMLSchema#string

Jonathan F Tait

http://www.w3.org/2001/XMLSchema#string

Ming Yu

http://www.w3.org/2001/XMLSchema#string

Peter S Nelson

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

Comprehensive molecular characterization of human colon and rectal cancer

Recurrent rearrangements in prostate cancer: causes and therapeutic potential

Integrated genomic characterization of endometrial carcinoma

Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations

Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence.

Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers.

Androgen receptor-driven chromatin looping in prostate cancer.

ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.

P2888

P304

4988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS5988

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266152891

http://www.w3.org/2001/XMLSchema#string

P6179

1009369436

http://www.w3.org/2001/XMLSchema#string

P698

25255306

http://www.w3.org/2001/XMLSchema#string

P921

P932

4176888

http://www.w3.org/2001/XMLSchema#string